Meaningful Contributions

George Morrow, M.A. ’77, Appointed to Human Genome Sciences Board of Directors

Posted April 21, 2011

Human Genome Sciences, Inc., a biopharmaceutical corporation that uses the human DNA sequence to develop protein and antibody drugs, announced in March that George Morrow, M.A. ’77, had been appointed to the HGS Board of Directors. Until January 2011, Morrow served as executive vice president for global commercial operations for Amgen, Inc., leading all of […]